Table 1.
Demographic | Result |
---|---|
Total Enrolled | 22 |
Age – mean (range) years | 62 (37 – 83) |
Gender – male/female | 9 / 13 |
Primary Disease | |
Colorectal | 8 |
Lung (total) | 8 |
Adenocarcinoma | 4 |
Squamous cell | 3 |
Other | 1 |
Anal | 2 |
Head and Neck | 4 |
Lines of Chemotherapy for Metastatic/Recurrent Disease – mean (range) | 3.6 (1 – 11) |
Prior anti-EGFR therapy | 13 (59%) |
cetuximab | 8 |
Erlotinib | 2 |
Multiple anti-EGFR agents | 3 |